Evidence map›Paper›PMID 33549980›Full record

ArticleSchizophrenia research2021

Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis.

Amy Higgins, Kathryn Eve Lewandowski, Saran Liukasemsarn, Mei-Hua Hall

Abstract read
In one paragraph

Article in Schizophrenia research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amy HigginsSchizophrenia and Bipolar Disorders Program, McLean Hospital, Harvard Medical School, Belmont, MA, USA; Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Kathryn Eve LewandowskiSchizophrenia and Bipolar Disorders Program, McLean Hospital, Harvard Medical School, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Saran LiukasemsarnSchizophrenia and Bipolar Disorders Program, McLean Hospital, Harvard Medical School, Belmont, MA, USA; Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Mei-Hua HallSchizophrenia and Bipolar Disorders Program, McLean Hospital, Harvard Medical School, Belmont, MA, USA; Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: mhall@mclean.harvard.edu.

Funding

Neurobiological Markers as Predictors of Later Functional Outcome in First Episode PsychosisR01MH109687 · NIMH · MCLEAN HOSPITAL · PI HALL, MEI-HUA · 2016 to 2021
$2.5M
Neuroprogression across the Psychosis Spectrum in the Early Course of IllnessR01MH117012 · NIMH · MCLEAN HOSPITAL · PI LEWANDOWSKI, KATHRYN EVE · 2019 to 2023
$2.4M
NIMH NIH HHS R01 MH109687NIMH NIH HHS R01 MH117012
6 · The paper itself

Abstract

backgroundReduced mismatch negativity (MMN) is observed in early psychosis (EP) and correlated with cognition and functioning, but few studies have examined their longitudinal relationships and diagnostic specificity. We examined MMN, neuro- and social-cognition, and functional measures in EP patients with schizophrenia-spectrum (SZ) or bipolar disorder (BD) over a 1-year follow-up.

methods54 EP patients (SZ: n = 24; BD: n = 30) and 42 healthy controls completed baseline measures: MMN, neuro- and social-cognition, and functional assessments. 30 EP patients completed 12-month follow-up assessments. Patients and controls were compared on MMN at baseline and follow-up, and diagnostic subgroup analyses were performed. Associations amongst MMN, neuro- and social cognition, and clinical measures were examined and predictive models of follow-up outcomes were conducted.

resultsEP patients showed significantly reduced MMN compared to controls at baseline (p = 0.023). MMN was impaired in SZ patients at baseline (p = 0.017) and follow-up (p = 0.003); BD patients did not differ from controls at either timepoint. MMN was associated with symptom severity and functioning at baseline, and with social cognition and functioning at follow up, but was not predictive of functional outcomes at follow-up.

conclusionsMMN abnormalities were evident in EP SZ-spectrum disorders at both timepoints, but not in BD at either timepoint. MMN was associated with functioning cross-sectionally, but did not predict future functional outcomes. However, deficits in MMN were associated with social cognition, which may have downstream effects on community functioning. Implications for targeted interventions to improve social processing and community outcomes are discussed.

Indexed as

Bipolar DisorderPsychotic DisordersSchizophreniaCognitionElectroencephalographyEvoked Potentials, AuditoryHumansCognitionEarly psychosisFunctioningLongitudinalMismatch negativity

Identifiers

PMID33549980
PMCPMC7987838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.